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The liver has been suspected to be one of the major targets of dengue virus infection. Here, we detected increasing
secretion of the chemokine RANTES (regulated upon activation, normal T cell expressed and secreted), which functions to
recruit the immune cells, in dengue-virus-infected liver cells and patients. Three luciferase reporter genes with various
deletions at the 59-end of the RANTES promoter were constructed to explore the RANTES activation mechanism in human
liver cells. The reporter gene was optimally activated by dengue-2 virus when the RANTES promoter contains the region from
the transcription starting site (11) to the nucleotide at the 2181 position. NF-IL-6 and an undefined factor forming
DNA–protein complexes in the RANTES promoter E and A/B regions in the infected cells were demonstrated by electro-
phoretic mobility shift assay. Further analysis showed that oxidative stress was an upstream inducer of NF-IL-6 and RANTES
signaling in dengue-virus-infected liver cells. This finding was demonstrated by three antioxidants (N-acetyl-L-cysteine,
nitro-L-arginine methyl ester, and pyrrolidine dithiocarbamate) used to suppress the activation. In contrast, the DNA binding
activity of the undefined factor was not affected by the antioxidant treatment, indicating the existence of an oxidant-
independent pathway. We hypothesize that dengue virus infection of the liver cells may trigger both an oxidant-dependent and
an oxidant-independent pathway to up-regulate RANTES mRNA expression through activating NF-IL-6 and an undefined
factor, respectively. In conclusion, the present study suggests a new direction for the study of liver pathogenesis involving
RANTES in host immune responses during dengue virus infection. © 2000 Academic Press
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INTRODUCTION
Patients with dengue virus infection show a wide
range of clinical syndromes, from mild fever to life-
threatening symptoms of hemorrhagic fever and/or
shock syndrome (DHF/DSS) (Halstead, 1989). The clin-
ical features of DHF include plasma leakage, a ten-
dency to bleed, and liver involvement (Rothman and
Ennis, 1999). Because the liver is the major organ
synthesizing most of the hemostatic factors (such as
fibrinogen and coagulation factors) (Pereira et al.,
1996), and because hemostatic abnormalities are in-
volved during the progression of DHF/DSS (Hathirat et
al., 1993), the relationship between liver cells and
DHF/DSS cannot be excluded. Clinical observations
have detected dengue virus antigen in hepatocytes,
and virus particles have been recovered from the liver
biopsies of DHF patients (Burke, 1968; Halstead, 1989;
Rosen et al., 1989; Couvelard et al., 1999). Recently, a
mouse model further confirmed that the liver plays a
pathogenic role during dengue virus infection and
might be one of the important targets for dengue virus1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 886-6-208-2705. E-mail: a713@mail.ncku.edu.tw.
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infection (An et al., 1999). Extensive studies have con-
centrated on the relationship between dengue virus
and monocytes, lymphocytes, or endothelial cells
(Krishnamurti and Alving, 1989; Avirutnan et al., 1998;
Hober et al., 1998), but the relationship between den-
gue virus and liver cells has rarely been explored. In a
previous report, however, we demonstrated that den-
gue-2 virus could replicate and cause evident cyto-
pathic effects (CPE) in different liver cell lines (Lin et
al., 2000).
RANTES (regulated upon activation, normal T cell
expressed and secreted), a member of the C-C che-
mokine family, was originally cloned from CD81 T
lymphocytes (Schall et al., 1988) and has chemotactic
activity for eosinophils (Rot et al., 1992), basophils
(Dahinden et al., 1994), monocytes (Schall et al., 1990),
NK cells (Taub et al., 1995), and T lymphocytes (Schall
et al., 1990). Infection of some viruses has been shown
to induce RANTES expression in a wide variety of cells
(Avirutnan et al., 1998; Matsukura et al., 1998; Thomas
et al., 1998). Thus, virus-induced RANTES expression
could be a major element in the pathogenesis of viral
infection. Increased RANTES secretion in dengue-vi-
rus-infected patients and liver cell lines was also
found in this study.
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ATESRANTES could be activated differently by different
stimuli, indicating a wide range of control at the tran-
scriptional level (Nelson et al., 1993, 1996; Moriuchi et al.,
1997; Ortiz et al., 1997). The 59-region of the RANTES
gene is divided into five regions (A–E) (Ortiz et al., 1997).
he A/B region contains a consensus NF-kB binding site
(258 to 227 nt), which can bind the transcription factors
including those of the NF-kB-Rel family and non-Rel
family (Nelson et al., 1996; Song et al., 1999), and the E
egion contains a consensus NF-IL-6 binding site (2100
o 292 nt). NF-IL-6, a member of the basic leucine zipper
rotein family, containing the CCAAT/enhancer-binding
rotein (C/EBP) domain (Brasier and Kumar, 1994), is
esponsible for the regulation of many acute-phase pro-
eins and cytokines in hepatocytes (Matsusaka et al.,
993). NF-IL-6 similar to some transcription factors could
e regulated by oxidants when host cells responded to
ifferent types of inflammatory stimuli and caused an
mbalance of the redox status (Jaspers et al., 1997, 1998).
t has been demonstrated that viral infection can activate
he transcription factors and lead to the activation of
pecific cellular gene expression through alteration of
he redox status (Mastronarde et al., 1995, 1998; Knobil et
al., 1998). Whether dengue virus infection of liver cells
can induce a similar host response has not been re-
ported.
During the outbreak of dengue virus infection in south-
ern Taiwan from Nov. 1998 to Jan. 1999, we detected
higher RANTES levels in patients infected with dengue
virus. In this study, we found a correlation between den-
gue virus infection and up-regulated RANTES gene ex-
pression in liver cells. Moreover, we found that the signal
pathway of dengue-virus-induced RANTES production
FIG. 1. Increased RANTES secretion in patients with dengue virus
nfection. Sera from patients were evaluated for RANTES level using an
LISA kit (Endogen, Woburn, MA). The data were analyzed statistically
y the Wilcoxon–Mann–Whitney test. Dengue virus: 12 patients with
engue virus infection. OFI hepatitis: 9 patients with other febrile illness
nd hepatitis. OFI: 14 patients with other febrile illness and without
epatitis. Hepatitis: 12 patients with hepatitis and without other febrile
llness. Normal: 10 individuals of healthy control.
DENGUE VIRUS ACTIVwas associated with induced oxidative stress and the
increased binding activity of NF-IL-6.RESULTS
RANTES secretion is higher in patients with dengue
virus infection
Serum samples from 12 patients infected with den-
gue-3 virus (3 with DHF/DSS and 9 with dengue fever
(DF)) were analyzed for RANTES secretion by enzyme-
linked immunosorbant assay (ELISA) during the course
of the fever. Because only limited patients with dengue
virus infection were available, we conducted a Wilcoxon–
Mann–Whitney test to show that RANTES levels were
significantly higher (P , 0.001) in patients with dengue
virus infection (447.6 6 227.0 ng/ml) compared to pa-
tients with other febrile illness (OFI) plus hepatitis (88.1 6
115.2 ng/ml), with OFI only (60.8 6 33.9 ng/ml), with
epatitis only (7.8 6 12.0 ng/ml), and healthy controls
34.1 6 29.0 ng/ml) (P , 0.001) (Fig. 1). No significant
ifference was detected between patients with DHF/DSS
nd DF (Table 1). Correspondingly, all of these patients
howed abnormally higher serum levels of liver
ransaminases (AST and ALT); nevertheless, no correla-
ion between RANTES levels and liver transaminases
as detected (Table 1).
engue virus infection induces RANTES expression
t protein and mRNA levels in liver cells
To test whether dengue virus infection of host cells
nduces RANTES secretion, we analyzed the RANTES
evel by ELISA in dengue-virus-infected cells. Table 2
hows that RANTES levels increased in dengue-2- and
engue-3-virus-infected Chang liver cells. Dengue-3 vi-
us induced a lower level of RANTES secretion than
engue-2 virus. In liver cells without infection or with
TABLE 1
Increased RANTES, AST, and ALT Levels in the Serum of Patients
with Dengue Virus Infection
RANTES (ng/ml)
AST (U/L)
(normal ,37)
ALT (U/L)
(normal ,40)
DHF/DSS
1 220 6 1.7 255 86
2 585 6 9.4 438 187
3 753 6 68.9 334 174
DF
1 478 6 25.2 182 86
2 193 6 6.4 210 160
3 518 6 29.7 810 409
4 419 6 26.9 49 32
5 190 6 4.9 289 288
6 667 6 21.1 412 264
7 255 6 2.4 233 274
8 427 6 4.0 185 167
Note. The aminotransferase (AST and ALT) activities were measured
115RANTES EXPRESSIONwith a routine automatic analyzer (Hitachi 747, Kawasaki, Japan) in the
clinical analysis laboratory of National Cheng Kung University Hospital.
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1heat-inactivated-virus treatment, RANTES secretion was
undetectable. Enterovirus 71 (EV-71) and coxsackievirus
B3, which we found able to infect liver cells and cause
CPE, could not induce RANTES secretion in liver cells
(Table 2). In addition to Chang liver cells, dengue-2 virus
infection induced RANTES secretion in other liver cell
lines, including Hep3B and HuH-7. Dengue virus could
also induce RANTES expression in the human microvas-
cular endothelial cell-1 (HMEC-1) (Table 2).
To address the regulation of dengue-virus-induced
RANTES secretion, we detected RANTES expression at
mRNA levels in dengue-virus-infected cells by Northern
blotting using human RANTES cDNA as the probe. Be-
cause dengue-2 virus showed higher infectivity in the
cell culture system than dengue-3 virus, we used den-
gue-2 virus in the following experiments to investigate
the host responses. Three liver cell lines were infected
with dengue-2 virus (100 m.o.i.) and the RNA was har-
vested at 42 h p.i. for detection of RANTES expression.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
gene expression was used as an internal control. Figure
2A shows that RANTES mRNA expression was evidently
induced at 36 h p.i. and reached a very high level at 42 h
p.i. in Chang liver, Hep3B, and HuH-7 cells. In our pre-
vious report (Lin et al., 2000), dengue-virus-induced CPE
n liver cells was observed initially at 36 h p.i. and
ecame severe at 48 h p.i. Moreover, the virion produc-
ion in dengue-virus-infected liver cells started after
assing the eclipse phase (12 h p.i.) and increased to a
lateau at 36 h p.i. The induction of RANTES expression
as parallel to the virus-induced CPE and the kinetics of
irus replication. This indicates the association between
he dengue virus up-regulated RANTES expression and
he virus infection. We tried to confirm our findings using
T
RANTES Secretion Increas
RANT
Cell lines
Mockb
infection
Inactivatedc
virus
Liver cells
Chang liver ,2 ,2
HuH-7 ,2 ,2
Hep3B ,2 ,2
ndothelial cells
HMEC-1 10.1 6 1.7 23.5 6 2.3
a Values are the means of duplicate experiments. The minimal level
b Cells without virus infection.
c Cells treated with heat-inactivated virus (at 56°C for 30 min).
d Cells infected with 100 m.o.i. of viruses.
e Cells infected with 1 m.o.i. of viruses.
16 LINrimary liver cells. Because of the difficulty in culturing
uman primary liver cells, we utilized mouse primary iiver cells in our study as a substitution. We found that
ouse primary liver and brain cells could be infected by
engue-2 virus and induced to express RANTES by RT-
CR detection (Fig. 2B). Collectively, both the protein and
he mRNA levels of RANTES were obviously elevated in
engue-virus-infected cells.
engue-Virus-Infected Cells
/ml)a
gue-2d
irus
Dengue-3e
virus EV-71d
Coxsackie-
virus B3d
6 8.4 56.7 6 0.1 ,2 ,2
6 3.1
6 7.3
6 3.3
sitive RANTES expression is 2 pg/ml by ELISA.
FIG. 2. Activation of RANTES mRNA expression in dengue-2-virus-
infected host cells. (A) Total cellular RNA was extracted from 100 m.o.i.
of dengue-2-virus-infected Chang liver, Hep3B, and HuH-7 cells at the
times indicated for Northern blot analysis. The 317- and 1250-bp frag-
ments, respectively, from RANTES and GAPDH cDNA were labeled
with [a-32P]dCTP for specific probes. (B) Mouse primary liver and brain
cells were respectively infected with 100 m.o.i. of dengue-2 virus and
the total cellular RNA was extracted at 48 h p.i. for detection of RANTES
L.ABLE 2
es in D
ES (pg
Den
v
776.4
176.6
523.3
45.9
for po
ET Aand viral (2) RNA by RT-PCR. The detection of b-actin was used for the
nternal control. D2, dengue-2 virus; IV, heat-inactivated virus.
AATESActivation of the RANTES reporter genes in the
dengue-2-virus-infected liver cells
To clarify that dengue-2 virus infection increased the
transcription of the RANTES gene, a luciferase reporter
gene driven by a RANTES promoter was constructed,
and the promoter activity was evaluated. Deletions by the
restriction enzyme digestion (BamHI, SacI, and MspI) of
the RANTES promoter region were made to generate the
constructs with nucleotides 2881, 2181, and 279 to the
transcription start site (11) and named pGL-A (2881 ;
154), pGL-B (2181 ; 154), and pGL-C (279 ; 154),
respectively (Fig. 3A). After transient transfection of the
reporter plasmids, Chang liver cells were infected with
either dengue-2 virus or heat-inactivated virus, and the
cell lysates were harvested at 42 h p.i. for luciferase
activity assay. Similar to heat-inactivated dengue virus,
EV-71 could not activate the RANTES reporter plasmids,
and it was used as a negative control. The luciferase
activity of RANTES reporter genes pGL-A and pGL-B in
the dengue-2-virus-infected cells was significantly higher
than that of the heat-inactivated-virus-treated or EV-71-
infected cells (P , 0.05) (Fig. 3B). The pGL-A gene,
which showed a lower luciferase activity than pGL-B,
seems to contain a region for negative regulation of
RANTES expression. The luciferase activity was lost in
the reporter of pGL-C, indicating that the E region (279 to
2181) is critical for induction of RANTES expression.
The luciferase activity of the pGL-B reporter gene
increased with infection time (1.5-fold at 24 h p.i. and
3.6-fold at 42 h p.i.) (Fig. 3C), which was consistent with
the increase in RANTES mRNA levels (Fig. 2). Similarly,
neither heat-inactivated virus nor mock infection acti-
vated the RANTES reporter gene. RANTES reporter gene
activity was also induced in dengue-2-virus-infected
Hep3B and HuH-7 cells (Fig. 3D). Promoter activation
between these cell lines was similar in pattern to the
induction of RANTES protein secretion (Table 2).
The formation of NF-IL-6–protein complex increases
in dengue-2-virus-infected liver cells
We further identify the essential region in the RANTES
promoter for the induction of RANTES expression by
dengue-2 virus infection. The region between 2181 to
279 nt of the RANTES promoter in the pGL-B reporter
contains the consensus binding site for NF-IL-6 (2100 to
292 nt) (Nelson et al., 1993). To determine whether the
activation of the RANTES promoter is caused by binding
of activated NF-IL-6 to the promoter, nuclear extracts
from cells infected with either dengue-2 virus or heat-
inactivated virus were mixed with [g-32P]ATP-labeled oli-
gonucleotide of the NF-IL-6 binding site for an electro-
phoretic mobility shift assay (EMSA). Intensive bands
representing a DNA–protein complex were observed in
DENGUE VIRUS ACTIVthe dengue-virus-infected cells at 12, 24, and 36 h (Fig.
4A, lanes 4–6). The DNA–protein complex was NF-IL-6
s
tspecific, because a 100-fold excess of the same unla-
beled oligonucleotide efficiently competed with the com-
plex formation (Fig. 4B, lane 4), whereas an oligonucle-
otide containing the NF-kB binding sequence (RANTES
/B site) failed to compete (Fig. 4B, lane 3). NF-IL-6-
FIG. 3. Activation of RANTES promoter activity in dengue-2-virus-
infected liver cells. (A) The RANTES promoter region was deleted by
the restriction enzymes BamHI, SacI, and MspI to create the luciferase
reporter plasmids pGL-A (2881 ; 154), pGL-B (2181 ; 154), and
pGL-C (279 ; 154). (B) The three RANTES promoter reporters, pGL-A,
pGL-B, and pGL-C (1 mg), were transiently transfected into Chang liver
cells in a 24-well plate using Lipofectin transfection reagent (BRL). The
cells were infected with dengue-2 virus, heat-inactivated virus, or EV-71,
and the luciferase activity of cell lysate was measured at 42 h p.i. The
data shown represent the means of triplicate data, and the experiments
were repeated three times. The data were analyzed by the Wilcoxon–
Mann–Whitney test (P , 0.05). (C) The pGL-B RANTES reporter gene
was transiently transfected into Chang liver cells and treated with
either dengue-2 virus for 24 and 42 h or heat-inactivated virus or mock
infection (C) for 42 h. The cell lysates were harvested and analyzed as
described in B. (D) The RANTES pGL-B reporter gene was transiently
transfected into Hep3B, HuH-7, and Chang liver cells, which were then
infected with either dengue-2 virus or heat-inactivated virus. The lucif-
erase activities were analyzed at 42 h p.i.
117RANTES EXPRESSIONpecific antibody was also used to clarify the composi-
ion of the binding complex. Figure 4B shows that the
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in comNF-IL-6–protein complex was supershifted by the anti-
body against NF-IL-6/C/EBPb (lane 2), indicating specific
inding by NF-IL-6. Moreover, the formation of binding
omplex with NF-IL-6 increased with infection time (Fig.
A, lanes 4–6), which was consistent with the induction
f RANTES promoter (Fig. 3C), indicating the close rela-
ionship between NF-IL-6 and RANTES gene expression.
he formation of RANTES A/B–protein complex
ncreases in dengue-2-virus-infected liver cells
We examined whether dengue virus would increase
he binding activity for RANTES A/B site (258 to 227 nt).
uclear extracts from the cells infected with dengue-2
irus or inactivated virus were incubated with the
g-32P]ATP-labeled oligonucleotide of the RANTES A/B
ite. Dengue-2 virus infection increased the formation of
he RANTES A/B site–protein complex at 24 h p.i., sug-
esting the involvement of the A/B site during dengue
irus infection (Fig. 5A, lane 5). The A/B site–protein
omplex formed by TNF-a stimulation was used as a
positive control (Fig. 5A, lane 7). Heat-inactivated virus
could not increase the A/B–protein complex (Fig. 5A,
lanes 1–3). The unlabeled A/B oligonucleotide added at
FIG. 4. Activation of NF-IL-6 binding to the NF-IL-6 site in dengue-2-v
The nuclear extracts harvested from Chang liver cells infected with de
36 h p.i. Nuclear protein (5 mg) was incubated with [g-32P]ATP-labeled o
in 5% polyacrylamide gel. (B) Involvement of NF-IL-6 in the NF-IL-6–prot
The nuclear extracts were then harvested to clarify the existence of N
oligonucleotide containing NF-IL-6 site (C-NF-IL-6; lane 4) or RANTES A
The anti-NF-IL-6/C/EBPb antibody (a-NF-IL-6; lane 2) or anti-p50 antib
binding complex for supershift analysis. *The supershifted DNA–prote
118 LIN100-fold excess into the reaction solution efficiently sup-
pressed the complex formation (Fig. 5B, lane 4), indicat-
y
bing that A/B site–protein complex formation is sequence
specific.
The A/B site with the sequence homologous to the
NF-kB binding site could bind with diverse proteins,
including members of the NF-kB-Rel family. In the NF-
kB-Rel family, p65 and p50 heterodimers were formed in
the dengue-virus-infected endothelial and hepatoma
cells (Marianneau et al., 1997; Avirutnan et al., 1998).
Therefore, we investigated whether p65 and p50 sub-
units are responsible for the A/B site–protein complex in
dengue-2-virus-infected liver cells. Figure 5B shows that
when treated with TNF-a, both anti-p65 and -p50 mono-
lonal antibodies recognized the A/B site–protein com-
lex, which resulted in band shifting, indicating that p65
nd p50 are involved in the A/B site–protein complex
Fig. 5B, lanes 7 and 8). Another protein also bound to the
/B site, which was not affected by either anti-p65 or
p50 antibodies (Fig. 5B, lanes 7 and 8). For dengue-2-
irus-infected cells, anti-p65 and -p50 antibodies could
ot supershift the A/B site–protein complex, indicating
hat a factor other than p65 and p50 is responsible for the
inding with the A/B site (Fig. 5B, lanes 2 and 3). Our
bservation was further confirmed by competition anal-
ected Chang liver cells. (A) Formation of the NF-IL-6–protein complex.
virus or heat-inactivated virus were analyzed by EMSA at 12, 24, and
leotide containing the NF-IL-6 binding sequence and electrophoresed
plex. Chang liver cells were infected with 100 m.o.i. of dengue-2 virus.
n the complex at 24 h p.i. A 100-fold molar excess of either unlabeled
(C-A/B; lane 3) was added to compete with the labeled oligonucleotide.
-p50; lane 1) (2 mg/20 ml reaction volume) was added to the labeled
plex.
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ATESwhich could not block formation of the A/B site–protein
complex in dengue-2-virus-infected Chang liver cells
(Fig. 5B, lane 5).
The induction of RANTES mRNA expression by
dengue-2 virus infection is inhibited by antioxidants
To evaluate whether the stimulated cellular gene ex-
pression by dengue virus infection was caused by in-
FIG. 5. Induction of the RANTES A/B site–protein complex formation
n dengue-2-virus-infected Chang liver cells. (A) Formation of RANTES
/B site–protein complex. Chang liver cells infected with either den-
ue-2 virus or heat-inactivated virus were harvested at 12-h intervals
or 36 h, and the nuclear extracts were analyzed by EMSA. Nuclear
rotein (5 mg) was mixed with [g-32P]ATP-labeled oligonucleotide con-
taining the A/B site and electrophoresed in 5% polyacrylamide gel.
TNFa: The cells were treated with TNFa (10 ng/ml) for 1 h and the
nuclear extract was then harvested for EMSA analysis. (B) Involvement
of an undefined protein in the A/B site–protein complex. Chang liver
cells were either infected with 100 m.o.i. of dengue-2 virus for 24 h (lane
1–5) or treated with TNFa (10 ng/ml) for 1 h (lanes 6–8), and then the
nuclear extracts were harvested for measuring RANTES A/B site bind-
ing activity by EMSA. Anti-p65 antibody (ap65; lane 2, 7) and anti-p50
ntibody (ap50; lane 3, 8) (2 mg/20 ml) were added for recognition of
F-kB in the A/B site–protein complex. A 100-fold molar excess of
unlabeled A/B site containing oligonucleotide (C-A/B; lane 4) or NF-kB
ite containing oligonucleotide (C-NF-kB; lane 5) was used as the
competitor for clarifying the specific binding. *The supershifted DNA–
protein complex.
DENGUE VIRUS ACTIVduced oxidative stress, we detected the redox status of
the dengue-virus-infected cells by measuring the ratio of
m
woxidized glutathione and total glutathione (GSSG/GSH),
an index of oxidative stress, in dengue-2-virus-infected
Chang liver cells. Figure 6A shows that dengue-2 virus
increased the GSSG/GSH ratio with infection time. A
two-fold increase is reached at 42 h p.i. (heat-inactivated
virus: 2.63%; dengue-2 virus: 5.22%), indicating that den-
gue-2 virus infection can induce oxidative stress in liver
cells. Furthermore, we clarified whether the induction of
RANTES expression by dengue-2 virus infection was
through induced oxidative stress. Three different antioxi-
dants were used: N-acetyl-L-cysteine (NAC), pyrrolidine
ithiocarbamate (PDTC), and N-nitro-L-arginine methyl
ster (L-NAME). GSH was combined with NAC to in-
rease the latter’s potency (Lomaestro et al., 1995).
hang liver cells were infected with dengue-2 virus and
reated with optimal doses of NAC plus GSH (Wakulich et
l., 1997), PDTC (Sumitomo et al., 1999), and L-NAME
Ishii et al., 1997) (5 mM, 1.6 mM, 10 mM, and 1 mM),
respectively. These antioxidants were not toxic to the
cells at these dosages. At 42 h p.i., the RNA was ex-
tracted for detection of RANTES mRNA by Northern blot
analysis. Figure 6B shows that all of the antioxidants
FIG. 6. Suppression of dengue-2 virus up-regulated RANTES mRNA
expression by antioxidants. (A) Increased GSSG/GSH ratio in dengue-
2-virus-infected Chang liver cells. Chang liver cells were infected with
either 100 m.o.i. of dengue-2 virus or heat-inactivated virus, and the cell
extracts were harvested at 24, 36, and 42 h p.i. for GSSG and GSH
analysis. (B) Suppression of dengue-2 virus induced RANTES expres-
sion by the antioxidants. Chang liver cells were adsorbed with
100 m.o.i. of dengue-2 virus for 2 h. The antioxidant NAC (5 mM) plus
GSH (1.6 mM), PDTC (10 mM), or L-NAME (1 mM) was then added to the
ells. Total cellular RNA was extracted for the detection of RANTES
119RANTES EXPRESSIONRNA by Northern blot analysis at 42 h p.i. GAPDH gene expression
as used as an internal control.
f
p
ET Aused effectively suppressed RANTES mRNA expression,
indicating that oxidants may be involved in the induction
of RANTES gene expression by dengue-2 virus infection
(lanes 3–5).
Activation of NF-IL-6–protein complex formation by
dengue-2 virus infection is suppressed by
antioxidants
To further confirm our hypothesis that oxidative stress
involves the activation of the transcription factor and the
induction of RANTES expression by dengue-2 virus in-
fection, NAC, L-NAME, and PDTC were used to study
whether they could affect the activation of the binding
complex with the NF-IL-6 or the RANTES A/B sites by
dengue-2 virus infection. The same treatment as that
described in Fig. 6B was applied to dengue-2-virus-in-
fected cells, and the nuclear extracts were harvested at
24 h p.i. to determine the binding complex for the NF-IL-6
or the RANTES A/B sites. Figure 7 shows that the binding
complex for the NF-IL-6 site was suppressed by these
antioxidants (lanes 8–10). In contrast, the binding com-
plex for the RANTES A/B site was not affected by these
antioxidants (Fig. 7, lanes 3–5).
DISCUSSION
FIG. 7. Antioxidants suppress the complex formation of NF-IL-6 with
its DNA binding site, but not the undefined factor with the A/B site. The
same treatment used in Fig. 6B was used. The nuclear extracts were
harvested at 24 h p.i. and analyzed for DNA binding activity with the
specific [g-32P]ATP-labeled oligonucleotide containing the RANTES A/B
(lanes 1–5) or NF-IL-6 binding site (lanes 6–10).
120 LINWe are the first to report that chemokine RANTES was
higher in patients infected with dengue-3 virus, as well
s
vas that RANTES mRNA and protein expression increased
in dengue-2-virus-infected liver cells. Further investiga-
tion revealed that RANTES promoter activity was en-
hanced. The region between the nucleotide position
2181 and the transcription initiation site (11) of the
RANTES promoter containing the consensus NF-IL-6 and
NF-kB binding sites was essential for activation. In den-
gue-2-virus-infected cells, NF-IL-6 and an undefined tran-
scription factor were activated to bind to this region.
Moreover, the GSSG/GSH ratio increased in dengue-2-
virus-infected liver cells. The antioxidants (NAC plus
GSH, L-NAME, and PDTC) were able to suppress the
formation of the NF-IL-6–protein complex as well as the
up-regulation of RANTES gene expression, but not the
binding activity of the undefined factor to the RANTES
A/B site. We therefore propose a model in which den-
gue-2 virus infection could trigger at least two signal
pathways. The first is oxidative stress, which induces an
oxidant-dependent signal pathway through NF-IL-6 to
modulate RANTES expression in the cells (Fig. 8). The
second is an oxidant-independent pathway, in which an
undefined factor binds to the RANTES A/B site to up-
regulate the RANTES gene. Both factors seem to be
required for full activation of RANTES gene expression
(Fig. 8).
It has been reported that infection of any serotype of
dengue viruses causes similar clinical symptoms
(Gubler, 1998). The severity of dengue disease depends
on the virulence of virus strains and the immune status of
the human host. Because of the mutability of the RNA
genome, dengue viruses change genetically when repli-
cated in the host. The genetic changes will possibility
increase virus replication, viremia, severity of disease,
and epidemic potential (Gubler, 1998). The dengue pa-
tients analyzed in this study were all confirmed to have
dengue-3 virus infection. Both dengue-2 and dengue-3
viruses could induce RANTES expression in liver cells
FIG. 8. A model for the induction of RANTES expression by dengue-2
virus infection in the infected liver cells. Dengue virus infection of liver
cells induces oxidative stress and activates NF-IL-6 binding to the
RANTES promoter, which can be inhibited by antioxidants, including
NAC, L-NAME, and PDTC. An undefined factor other than NF-kB-Rel
amily proteins is also activated but through an oxidant-independent
athway to bind to the A/B site of the RANTES promoter. Both factors
L.eem to be required for full activation of RANTES expression by dengue
irus infection in liver cells.
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ATES(Table 2). Dengue-3 virus infectivity and virus titer, how-
ever, are much lower than those of dengue-2 virus in the
cell culture system. To obtain significant cellular re-
sponses, we chose dengue-2 virus for the in vitro study.
The induction of RANTES expression by other viruses
was investigated as well. EV-71 and coxsackievirus B3
could infect liver cells and cause CPE, but could not
induce RANTES secretion in liver cells, indicating that
the induction of RANTES expression in liver cells was
dengue virus specific. Moreover, dengue-2 virus could
also induce RANTES expression in different types of
cells, such as HMEC-1 and mouse primary liver and
brain cells.
Some cytokines have been analyzed in this study.
Briefly, MIP-1b, another C-C chemokine, was induced.
IL-6 and IL-8 were also inducible, but the induction levels
were lower than that of RANTES. IL-10, IFN-g, TGF-b,
IL-2, and IL-4 were undetectable, and IL-1b and TNF-a
were constitutively expressed (data not shown). Compar-
atively, dengue virus infection of liver cells tended to
induce C-C chemokine expression including the specific
activation of RANTES expression. The significance be-
tween dengue virus and RANTES was demonstrated by
the following: (1) Patients with dengue virus infection had
increased RANTES secretion compared to other viral
infections, and (2) Induction of RANTES secretion in liver
cells was specific for dengue virus infection but not for
EV-71 or coxsackievirus B3 infection. These results sug-
gest that RANTES may be an important factor in the
pathogenesis of dengue virus infection. RANTES secre-
tion from dengue-virus-infected cells may recruit immune
cells to the inflammation sites. The balance of virus
elimination and tissue damage will determine the sever-
ity of the disease.
It has been reported that the IFN-a level increased in
engue fever patients and that activated lymphocytes
ould express IFN-a to inhibit dengue virus infection in
ormal cells (Kurane et al., 1987, 1993). Hepatocytes,
owever, produce undetectable levels of type I IFN after
irus infection (Keskinen et al., 1999). It is possible that
iver cells with dengue virus infection may recruit lym-
hocytes through RANTES expression, and then the ac-
ivated lymphocytes will increase the host defense
gainst viral infection through production of type I IFN.
RANTES levels were significantly higher in patients
ith dengue virus infection compared to patients with
on-dengue infections, and the patients with dengue
nfection also had increased liver transaminases in their
erum. However, the correlation between RANTES and
iver transaminase was not significant. It is probably that
1) the liver transaminases in the serum are secreted
ainly by an injured liver and were induced by either the
irect effect of virus infection or the host immune re-
ponse. The direct effect was supported by our investi-
DENGUE VIRUS ACTIVation that dengue virus actively replicated in liver cells
nd increased the release of liver transaminases (Lin et
c
tl., 2000). (2) RANTES in serum, however, can be re-
eased by many sources, in addition to the liver. For
xample, we found that dengue-2 virus also induced
ANTES expression in endothelial and brain cells.
herefore, accumulation of RANTES in serum does not
epresent damage of the liver. Nevertheless, our in vitro
tudy proved that dengue virus infection could definitely
nduce RANTES expression in the liver cells.
Our data clearly demonstrate the relationship between
F-IL-6 and dengue virus up-regulated RANTES expres-
ion based on the following evidence: (1) The induction
f RANTES promoter activity was lost after the deletion of
he region containing the NF-IL-6 binding sequence (Fig.
B); (2) The formation of the NF-IL-6–protein complex
as activated in dengue-2-virus-infected cells and the
ctivation occurred simultaneously with the induction of
ANTES expression (Fig. 4A); and (3) RANTES expres-
ion and the formation of the NF-IL-6–protein complex
ere suppressed simultaneously by antioxidants (Figs.
B and 7). It has been reported by many investigators
hat gene activation needs the synergistic control of two
ranscription factors (Mastronarde et al., 1996; Jaspers et
l., 1997). For example, NF-IL-6 together with NF-kB
could induce IL-8 expression in RSV-infected epithelial
cells (Mastronarde et al., 1996). Similarly, we found that
NF-IL-6 and an undefined factor were activated to bind
the RANTES promoter in dengue-2-virus-infected cells.
The binding of the undefined factor to the A/B site alone
was not sufficient to induce RANTES expression. There-
fore, we suggest that induction of RANTES expression by
dengue virus infection in liver cells needs the coordinate
activation of at least two factors which bind to NF-IL-6
and the A/B site of the promoter.
It has been reported that NF-kB binds to the A/B site of
he RANTES promoter and is involved in the activation of
ANTES promoter (Nelson et al., 1996; Moriuchi et al.,
997; Ray et al., 1997; Thomas et al., 1998). Avirutnan et
al. and Marianneau et al. also reported that the p65 and
50 subunits of NF-kB were activated in dengue-2-virus-
infected liver cells (Marianneau et al., 1997; Avirutnan et
al., 1998). Our analysis, however, showed that a factor
other than NF-kB heterodimer (p50 and p65) forms the
A/B site–protein complex in dengue-virus-infected liver
cells. This finding was clarified by using the NF-kB in-
hibitor SN50 (containing the p50 NF-kB subunit NLS),
hich inhibited the TNF-a-activated RANTES expression
ut had no effect on RANTES expression activated by
engue-2 virus infection (data not shown). All of the data
ndicate that the factor responsible for binding with the
/B site is not NF-kB. Recently, a non-Rel protein,
RFLAT-1 (RANTES factor of late-activated T lymphocytes-
1), bound to the A/B site was cloned and was confirmed
to be a transactivator of the RANTES gene in T cells
(Song et al., 1999). Moreover, in IL-1b-stimulated astro-
121RANTES EXPRESSIONytes, the transcription factors SP1 and SP3 also bound
o the A/B site of the RANTES gene (Song et al., 1999).
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formation of the A/B site–protein complex in liver cells.
Further study is necessary to clarify this unknown factor.
The reason that the band intensity of the RANTES A/B
site complex increased at 24 h but dropped at 36 h after
dengue virus infection is probably that this DNA–protein
complex is more liable to degradation than the NF-IL-6–
complex (Fig. 5A, lane 6). At a later stage of infection,
when the host cell has been severely damaged by den-
gue virus infection, this protein complex for the RANTES
A/B site may become vulnerable to degradation. Never-
theless, this protein complex binding to the A/B site
seems not to play a pivotal role in dengue virus up-
regulated RANTES expression.
GSH functions to maintain the redox status of the cells
and is a substrate of GSH peroxidase, which metabolizes
GSH to its oxidized form (GSSG) and then converts H2O2
to H2O to reduce generation of the hydroxyl radical (•OH).
hus, the increase of the GSSG/GSH ratio in the dengue-
irus-infected liver cells represents the induction of oxi-
ative stress (Lomaestro and Malone, 1995; Hara et al.,
996). Three distinct antioxidants were used in our study:
1) NAC, a free radical scavenger, is a cysteine prodrug
or maintaining intracellular thiol concentration and re-
lenishing GSH in deficiency status (Lomaestro and Ma-
one, 1995); (2) L-NAME, an inhibitor of nitric oxide syn-
thase (NOS) (Moroz et al., 1998), can block the genera-
tion of ROS from NOS (Ishii et al., 1997); and (3) PDTC, an
iron chelator, is a strong free radical scavenger (Wild and
Timothy, 1999). These antioxidants with different inhibi-
tion mechanisms could maintain the redox status as well
as suppress dengue-virus-induced RANTES mRNA ex-
pression. We have detected virus replication in antioxi-
dant-treated liver cells. Consistent with a previous report
(Schweizer and Peterhans, 1999), the antioxidants used
could not inhibit dengue-2 virus replication (data not
shown). These antioxidants also could not block dengue-
2-virus-induced CPE. Therefore, we suggest that these
antioxidants suppressed the dengue-2-virus-induced
RANTES expression through the prevention of oxidative
stress in the cells.
Exposure to ozone, a highly reactive oxidant gas, has
been reported to be able to induce the DNA binding
activities of NF-IL-6, which would further mediate the
expression of IL-8 in respiratory epithelial cells (Jaspers
et al., 1997, 1998). Similarly, our results show that den-
gue-2-virus-induced RANTES expression is mediated by
oxidative stress, which uses an unknown mechanism to
activate NF-IL-6 and then up-regulates the RANTES pro-
moter. It is the first evidence that dengue virus infection
may induce oxidative stress, which initiates the signal
transduction for chemokine RANTES expression. Never-
theless, two questions remain to be solved: (1) How does
dengue virus affect the oxidative condition in the infected
122 LINcell? Dengue virus replication probably inhibits cellular
protein synthesis and subsequently reduces the steady-state synthesis of antioxidant enzymes. Moreover, active
viral protein synthesis may disrupt the balance of the
redox in the host cells (Schweizer and Peterhans, 1999);
(2) How does the redox status increase the NF-IL-6
binding activity to the RANTES promoter? We have mea-
sured the protein level of nuclear NF-IL-6, but the expres-
sion was similar to the cells treated with either dengue
virus or heat-inactivated virus (data not shown). It sug-
gests that the dengue-virus-induced DNA binding activity
of NF-IL-6 is not caused by the increase of protein ex-
pression and nuclear translocation. Phosphorylation of a
threonine residue located just N-terminal to the DNA
binding domain by a ras-dependent MAP kinase has
been suggested to be responsible for NF-IL-6 activities
(Nakajima et al., 1993). Protein tyrosine kinase (PTK) and
rotein kinase A (PKA) activities were demonstrated as
he early events in the signal transduction cascade me-
iating the ozone-induced activation of NF-kB and NF-
IL-6 as well as the release of IL-8 (Jaspers et al., 1997,
1998). Whether PTK and PKA mediate the oxidative-
stress-induced NF-IL-6 activation in dengue-virus-in-
fected liver cells is worthy of further research.
In summary, we propose that dengue-2 virus may
induce oxidative stress, which up-regulates RANTES
mRNA expression in liver cells through activating NF-IL-6
to bind to the promoter. An undefined factor was also
activated and bound to the A/B site of the RANTES
promoter through an oxidant-independent pathway (Fig.
8). These two factors either contact directly or bind to-
gether through other unknown proteins to up-regulate
RANTES expression. Our study provides the signal path-
way for RANTES expression in dengue-2-virus-infected
liver cells, which will shed light on the regulation of
RANTES gene expression and pave the way for better
control of RANTES-involved viral diseases.
MATERIALS AND METHODS
Human serum
Serum was collected from 12 patients infected with
dengue virus (9 males and 3 females; age range: 4 to 37
years old). All had clinical symptoms of fever, rash, and
bone pain, and all were hospitalized in National Cheng
Kung University Hospital from Nov. 1998 to Jan. 1999.
Anti-dengue ELISA-IgM or RT-PCR was performed to
demonstrate dengue-3 virus infection by the National
Quarantine Service Department of Health in Taiwan. Di-
agnosis of DHF/DSS was based on the clinical criteria
established by the World Health Organization (World
Health Organization, 1980). All of these patients were
IgM anti-HBc negative. Serum samples were collected
during the course of their fever and stored at 270°C.
Serum samples were also collected from age-matched
individuals without antibodies against dengue virus, in-
L.cluding: (1) 9 patients at the acute stage of other virus
infections (other febrile illness) and with abnormally high
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ATESAST and ALT levels, (2) 14 patients with OFI and normal
AST and ALT levels, (3) 12 patients without febrile illness
and with abnormally high AST and ALT levels, and (4) 10
healthy people (controls). All serum samples were tested
in the same way for RANTES levels. All but the controls
had a confirmed febrile illness and confirmed AST and
ALT serum levels.
Cell lines and virus
Chang liver cells (a nonmalignant human liver epithe-
lial cell line) (Matsuguchi et al., 1990; Kim et al., 1998;
Amaro et al., 1999) and HuH-7 and Hep3B (human hep-
atoma cell lines) cells were cultured at 37°C in a 5% CO2
incubator. The cells were maintained in Dulbecco’s mod-
ified Eagle’s medium (DMEM) (Gibco-BRL, Grand Island,
NY), supplemented with 10% fetal bovine serum (FBS)
(TRACE, Australia), penicillin (200 unit/ml), and strepto-
mycin (100 mg/ml). The HMEC-1 cells were passaged
ontinuously in endothelial basal medium (Clonetics,
anta Ana, CA), supplemented with 10% normal human
erum (Irvine Scientific, Santa Ana, CA) (Xu et al., 1994).
he primary liver and brain cells from neonatal of BALB/c
ice were treated with 0.1% trypsin for 18 h and then
ultured in DMEM containing 30% FBS.
For virus infection experiments, cells were adsorbed
ith dengue-2 virus at the titer of 100 m.o.i. at 37°C for
h. The cells were then washed three times with phos-
hate-buffered saline (PBS) and incubated at 37°C in the
ormal medium.
Dengue-2 virus (PL0146 isolated from Taiwan) and
engue-3 virus (739079A) were maintained in C6/36
ells. The titer was evaluated in BHK-21 cells by plaque
ssay (Liu et al., 1997). Dengue-2 virus was used
hroughout the entire study at 100 m.o.i. Dengue-2 virus
as heated at 56°C for 30 min as inactivated virus
Avirutnan et al., 1998; Marianneau et al., 1999). EV-71
strain 4643 isolated from a patient in Taiwan) (Ho et al.,
999) and coxsackievirus B3 (strain H0297 isolated from
patient in Taiwan) (Wang et al., 1998) were prepared
rom Vero cells.
LISA for RANTES
Immunoreactive RANTES in serum or culture superna-
ant was determined using a commercial ELISA kit ac-
ording to the manufacturer’s instructions (Endogen,
oburn, MA).
NA extraction
Total cellular RNA was extracted by guanidine isothio-
yanate lysis buffer (4 M guanidine isothiocyanate, 25
M sodium citrate, 50 mM 2-mercaptoethanol, and 0.5%
arkosyl). The solution was sequentially mixed with 1/10
ol of 3 M sodium acetate (pH 5.2), an equal volume of
DENGUE VIRUS ACTIVater-equilibrated phenol, and 1/5 vol of chloroform.
fter centrifugation at 14,000 rpm for 20 min, the aqueoushase was combined with 2.5 vol of 95% ethanol to
recipitate the RNA. The resulting RNA was dissolved in
iethyl pyrocarbonate water (Sigma, St. Louis, MO) and
uantified by the absorbency at an optical density of 260
m (Liu et al., 1997).
Probes
An ApaI- and EcoRI-digested 317-bp fragment (Ray et
l., 1997; Schall et al., 1988) of human RANTES cDNA
99–415) from pBSRANTES and a PstI-digested 1250-bp
ragment of GAPDH cDNA from plasmid pIBI30GAPDH
Fort et al., 1985) were labeled with [a-32P]dCTP using a
megaprime DNA labeling system (Amersham, Bucking-
hamshire, UK).
Northern blotting
Total cellular RNA (30 mg) was denatured in glyoxal
solution containing 1 M glyoxal and 10 mM sodium
phosphate (pH 6.5) at 50°C for 1 h and electrophoresed
in 1% agarose gel at 80 V, 40 mA, for 2 h. The RNA gel
was then blotted to the Hybond-N membrane (Amer-
sham) through sodium phosphate transferring buffer (25
mM, pH 6.5). The blot was treated with UV-cross linker
(Spectrolinker, XL-1000, NY) and hybridized with the
[a-32P]dCTP-labeled probe (2 3 106 cpm/ml) (Liu et al.,
997).
T-PCR
Total cellular RNA (1 mg) was added with 0.5 mM of
oligo-dT or sense primer for dengue-2 virus cDNA and
denatured at 70°C for 10 min. The RNA mixture was then
incubated at 37°C for 50 min and mixed with 13 first-
strand buffer (Gibco-BRL), 0.5 mM dNTP, 10 mM DTT, and
200 U of MMLV-reverse transcriptase (Gibco-BRL). The
cDNA was further used for PCR amplification in the
reaction solution of 0.2 mM dNTP, 0.2 mM sense and
antisense primers, 13 reaction buffer (Kevin Science
Technology, Brea, CA), and 1 unit of Biothermal DNA
polymerase (Kevin Science Technology). The reaction
was then performed in a PCR thermal cycler (Perkin–
Elmer, OH) for 2 min at 94°C, followed by 30 cycles of
30 s at 94°C, 30 s at 51°C, 30 s at 72°C, and, finally, 10
min at 72°C (Liu et al., 1997). The primers for detection
were the following:
RANTES cDNA (101 bp) (Simecka, 1999);
sense: 59-CCACGTCAAGGAGTATTTCTACACC-39;
antisense: 59-TCTTCTCTGGGTTGGCACACAC-39;
dengue-2 cDNA (419 bp) (Liu et al., 1997);
sense: 59-GATATGGGTTATTGGATGGA-39;
antisense: 59-CTGATTTCCATCCCGTA-39;
b-actin cDNA (348 bp) (Bohn et al., 1994);
123RANTES EXPRESSIONsense: 59-TGGAATCCTGTGGCATCCATGAAAC-39;
antisense: 59-TAAAACGCAGCTCAGTAACAGTCCG-39.
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The human RANTES promoter region was obtained by
PCR of the human genomic DNA and the sequence was
confirmed by an automatic Procise sequencer (Applied
Biosystem Inc., Foster City, CA). A StuI- and KpnI-di-
gested 951-bp DNA fragment containing the entire
RANTES promoter region from the PCR product was
cloned into pSKII bluescript (Stratagene, La Jolla, CA).
Double digestion was conducted to generate the follow-
ing promoter regions: 2881 (BamHI)/154 (KpnI), 2181
SacI)/154 (KpnI), and 279 (MspI)/154 (KpnI), which
ere subcloned into the pGL-3 Basic luciferase reporter
ene plasmid (Promega, Madison, WI) and named
GL-A, pGL-B, and pGL-C, respectively (Fig. 3A). The
uciferase activities were determined by a dual-light lu-
iferase and b-galactosidase reporter gene assay sys-
tem (Tropix, Bedford, MA) using a luminometer (Minilu-
mate LB 9506, Germany) (Liu et al., 1999).
EMSA
The cells (2 3 106) were collected by centrifugation at
12,000 rpm for 10 s and suspended in 400 ml of ice-cold
buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, and 1.5 mM
MgCl2) with a mixture of protease inhibitors (0.5 mM
MSF, 0.5 mM DTT, 2 mg/ml leupeptin, 2 mg/ml pepstain,
12 ml/ml sodium orthovanadate, and 10 ml/ml NaF)
Boehringer Mannheim, Roche, Palo Alto, CA). After in-
ubation in ice for 10 min, the mixture was centrifuged at
2,000 rpm for 10 s. The pellet was suspended with 100
ml of buffer B (20 mM HEPES, pH 7.9, 420 mM NaCl, 0.2
mM EDTA, 1.5 mM MgCl2, 25% glycerol, and the mixture
f protease inhibitors) and incubated in ice for 20 min
nd then centrifuged at 14,000 rpm for 2 min at 4°C. The
upernatant was aliquoted and stored at 270°C. The
xperiments were repeated at least three times. Nuclear
xtract (5 mg) was incubated in a binding buffer contain-
ing 13 mM HEPES (pH 7.9), 50 mM NaCl, 0.1 mM EDTA,
0.5 mM DTT, 20 mg/ml salmon sperm DNA, and 40 mg/ml
oly (dI-dC) (Amersham Pharmacia Biotech, Piscataway,
J) in ice for 15 min, and then 0.3 ng of [g-32P]ATP
nd-labeled double-stranded DNA oligonucleotides was
dded to the nuclear protein mixture at room tempera-
ure for 30 min. Isotope-labeled oligonucleotides with or
ithout protein binding were separated by a 5% poly-
crylamide gel. The following oligonucleotides were
sed: RANTES A/B site: 59-TTTTGGAAACTCCCCT-
TAGGGGATGCCCCT CA-39 (Ray et al., 1997); NF-IL-6
binding site: 59-TGCAGATTGTGCAATGTACG-39 (Mastro-
narde et al., 1996); NF-kB binding site: 59-AGTT-
GAGGGGACTTTCCCAGGC-39 (Avirutnan et al., 1998).
The competition assay was conducted by adding 100-
fold excess of the unlabeled oligonucleotide to the nu-
clear extract mixture. For the supershift assay, 2 mg of the
124 LINdesired antibody against NF-kB subunit p50 (1191X;
anta Cruz Biotech, CA), p65 (372X; Santa Cruz Biotech.),r NF-IL-6/C/EBPb (SC-746X; Santa Cruz Biotech) was
added to the binding mixture. The mixture was incubated
in ice for 30 min before the labeled probe was added
(Ray et al., 1997).
GSH and GSSG assay
The total GSH levels were determined according to the
method of Anderson (Anderson et al., 1985). Briefly, cell
pellets were washed with PBS and resuspended in 1%
picric acid. Subsequently, samples were centrifuged at
14,000 rpm for 15 min. The supernatant was aliquoted
into 5 and 100 ml for GSH and GSSH detection, respec-
tively. For GSH detection, a mixture containing 5 ml of
sample, 200 ml of distilled water, 700 ml of 0.3 mM
educed form of b-nicotinamideadenine dinucleotide
phosphate, and 100 ml of 6 mM 3-carboxyl-4-nitrophenyl
isulfide was incubated at 30°C for 3 min. Finally, gluta-
hione reductase (5 ml of 200 U/ml) was added immedi-
tely before the absorbency was read. The rate of for-
ation of 2-nitro-5-thiobenzoic acid reflecting the
mount of total GSH was measured at 412 nm every 30 s
or 2 min with a spectrophotometer (DU 640B: Beckman
nstruments, Fullerton, CA). The total GSH levels in the
amples were calculated from a standard curve accord-
ng to the known amount of GSH versus the rate of
ormation of 2-nitro-5-thiobenzoic acid.
For GSSG detection, 100 ml of sample was mixed with
2 ml of 2-vinylpyridine (Acros, NJ) at room temperature for
30 min to destroy GSH, and the retained GSSG was
assayed as the procedure for GSH (Hara et al., 1996;
Nakamura et al., 1997).
Reagents
NAC, GSH, PDTC, and L-NAME were purchased from
igma Chemical Co.
tatistical analysis
Statistical analyses were performed with StatXact-3
ersion 3.0.1 for Windows (Cytel Software corporation,
ambridge, MA). Comparisons between groups were
ade using the Wilcoxon–Mann–Whitney test. The dif-
erence was considered significant if P , 0.05. The
orrelation coefficients were calculated using Pearson’s
orrelation coefficient. The correlation was considered
ignificant if P , 0.05.
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